+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Cartilage Repair/Cartilage Regeneration Market by Repair Technique, Targeted Site, Material Type, Source Type, Application, End-Users - Global Forecast to 2030- Product Image
Cartilage Repair/Cartilage Regeneration Market by Repair Technique, Targeted Site, Material Type, Source Type, Application, End-Users - Global Forecast to 2030- Product Image
Sale

Cartilage Repair/Cartilage Regeneration Market by Repair Technique, Targeted Site, Material Type, Source Type, Application, End-Users - Global Forecast to 2030

  • PDF Icon

    Report

  • 197 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 5201077
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Cartilage Repair/Cartilage Regeneration Market grew from USD 1.91 billion in 2024 to USD 2.09 billion in 2025. It is expected to continue growing at a CAGR of 10.49%, reaching USD 3.48 billion by 2030.

Pioneering Advances Shaping Cartilage Repair Dynamics

Cartilage repair and regeneration have rapidly evolved from niche surgical procedures into a robust market driven by technological breakthroughs and a growing global patient base. Advances in biomaterials science, cellular therapies, and minimally invasive techniques have converged to offer new hope for patients suffering from sports injuries, degenerative joint diseases, and congenital defects. The aging population worldwide and increasing prevalence of osteoarthritis underscore a pressing need for effective restorative solutions. Meanwhile, heightened patient expectations and improvements in imaging and diagnostic tools are raising the bar for clinical outcomes.

This dynamic landscape is shaped by collaborative efforts across academia, biotechnology, and medical device sectors. Ongoing research into stem cell biology, tissue scaffolding, and gene editing is blurring the lines between repair and regeneration, promising treatments that restore not only structure but also function. At the same time, regulatory agencies are refining guidelines to accommodate cutting-edge therapies. The market’s growth trajectory reflects both unmet clinical needs and a willingness among payers and providers to invest in long-term, cost-effective solutions that reduce the burden of repeat surgeries and chronic care.

Emerging Paradigms Redefine Healing Possibilities

Recent years have witnessed transformative shifts that are redefining the potential of cartilage therapies. Stem cell-based approaches have transitioned from preclinical promise to early-phase clinical trials, leveraging both adult and embryonic sources to harness chondrogenic capacity. Parallel developments in tissue engineering, including cell-based and scaffold-based platforms, are enabling personalized implants that align with patient-specific anatomy and biomechanical requirements.

Innovations in 3D bioprinting are accelerating prototype development and reducing time to first in-human applications. Digital imaging and computer-aided design facilitate precise defect mapping and surgical planning, elevating procedural accuracy and patient outcomes. Furthermore, novel biomaterials-ranging from hyaluronic acid derivatives to synthetic polymers like polyethylene glycol and polylactic acid-offer tunable mechanical properties and controlled degradation profiles. These converging technologies are creating a new paradigm that moves beyond symptomatic relief toward true tissue regeneration.

Assessing Cumulative Impacts of 2025 US Tariffs

The introduction of new tariffs by the United States in 2025 has created reverberations across the cartilage repair supply chain. Levies on imported medical devices, specialized metals, and consumable biomaterials have driven up manufacturing costs, prompting domestic and international suppliers to reevaluate sourcing strategies. In response, some companies have accelerated plans for local production while others have sought alternative low-cost materials to preserve margin structures.

These cost pressures have downstream effects on pricing negotiations with hospitals and outpatient centers. Providers are increasingly demanding value-based contracting and evidence of long-term cost savings in terms of reduced revision surgeries and lower chronic care expenses. At the same time, research collaborations and cross-border partnerships are evolving to mitigate tariff impacts through shared production facilities and technology transfers. Ultimately, the 2025 tariff landscape underscores the importance of agile supply chain management and diversified manufacturing footprints to sustain growth in cartilage repair markets.

Unveiling Layered Market Segmentation Insights

Insight into market segmentation illuminates the nuanced drivers of growth across therapeutic modalities and clinical contexts. When examining repair techniques, it becomes clear that traditional approaches such as microfracture, chondroplasty, mosaicplasty, and osteochondral autograft transplantation coexist with advanced cell therapies. Autologous chondrocyte implantation continues to hold a strong position in reconstructive strategies, while the emergence of stem cell-based regeneration-leveraging both adult and embryonic stem cells-and the parallel progress in tissue engineering through cell-based and scaffold-based techniques are reshaping long-term treatment paradigms.

Targeted anatomical site analysis reveals that knee cartilage dominates procedural volumes, but there is growing attention on hip, shoulder, ankle, and elbow interventions as minimally invasive methods and tailored grafts expand indications. Material type further differentiates market potential: natural biomaterials including chitosan, collagen, and hyaluronic acid display favorable biological integration, whereas synthetic polymers such as polyethylene glycol and polylactic acid offer customizable mechanical strength and degradation profiles. Source type adds another dimension, with allogeneic constructs providing off-the-shelf convenience and autologous approaches emphasizing immunocompatibility. Clinical application segments span elastic cartilage repair, fibrocartilage interventions, and hyaline cartilage restoration, each carrying distinct evidence thresholds and reimbursement considerations. Finally, end-user environments vary from high-volume hospital operating rooms to specialized orthopedic clinics and ambulatory surgical centers, influencing procedure adoption rates and capital investment requirements.

Navigating Regional Market Dynamics

Regional dynamics play a pivotal role in shaping the future of cartilage repair. In the Americas, a mature reimbursement infrastructure and proactive regulatory pathways support rapid commercialization of cellular and scaffold technologies. The demographic shift toward an older population and a highly active sports community drives sustained demand for restorative procedures.

Across Europe, the Middle East & Africa, regulatory harmonization efforts and cross-border clinical studies are fostering collaborative innovation hubs. National healthcare systems in Western Europe incentivize cost-effectiveness, propelling interest in therapies that reduce long-term care burdens. In contrast, emerging economies in the region are adopting market-access frameworks that balance affordability with technology uptake.

The Asia-Pacific region exhibits robust growth potential fueled by expanding healthcare infrastructure, rising disposable incomes, and government initiatives to bolster biotech manufacturing. Markets such as Japan, South Korea, China, and Australia are at the forefront of clinical research and local production, creating a competitive landscape that attracts global investment and strategic partnerships.

Competitive Landscape Through Key Player Strategies

The competitive landscape is defined by established medical device manufacturers, agile biotech firms, and emerging regenerative medicine startups. Major players have fortified their positions through strategic acquisitions, exclusive licensing deals, and co-development agreements with academic institutions. Some have focused on expanding portfolios to include both cell-based and scaffold-based solutions, while others are pursuing specialty biomaterials with patent-protected formulations.

Innovation hotspots include proprietary hyaluronic acid derivatives designed to optimize cell viability and next-generation cartilage matrices that mimic native extracellular architecture. Leading developers are also collaborating with surgical robotics companies to integrate precision delivery platforms, enhancing reproducibility and reducing operative times. Investment in clinical trials remains a top priority, as firms race to secure first-mover advantage in key therapeutic segments.

Strategic alliances between device manufacturers and contract research organizations are streamlining the path to market by combining technical expertise with advanced manufacturing capabilities. These partnerships enable rapid scale-up of production and accelerate regulatory submissions across multiple regions. Collectively, these competitive moves underscore the high stakes and significant capital flows driving momentum in cartilage repair and regeneration.

Pragmatic Recommendations to Elevate Market Position

To maintain and enhance competitive positioning, industry leaders must adopt a multifaceted strategy. Prioritizing investment in next-generation biomaterials and personalized cell therapies can differentiate product portfolios and address unmet clinical needs. Cultivating strategic partnerships with academic research centers and technology incubators accelerates innovation cycles and provides early access to promising breakthroughs.

Strengthening supply chain resilience through geographic diversification and dual sourcing of critical components mitigates the impact of trade policy shifts. Engaging with payers and healthcare systems to demonstrate long-term value and securing value-based reimbursement models will be essential as cost pressures intensify. Furthermore, integrating digital health tools-such as postoperative monitoring and patient-reported outcome platforms-can enhance real-world evidence generation and support market access efforts.

Finally, focusing on targeted regional expansion by tailoring go-to-market strategies to local regulatory and clinical landscapes ensures efficient resource allocation. By combining technological leadership with strategic collaborations and value-driven commercialization tactics, companies can navigate the evolving cartilage repair ecosystem and capture sustainable growth opportunities.

Comprehensive Research Methodology Overview

This analysis is founded on a rigorous blend of primary and secondary research methodologies. In-depth interviews with leading orthopedic surgeons, regenerative medicine experts, and senior executives provided qualitative perspectives on clinical adoption barriers, technological needs, and market trajectories. Concurrently, quantitative data were gathered from peer-reviewed publications, industry reports, regulatory databases, and corporate financial filings to triangulate market trends.

A systematic approach was applied to segment analysis, ensuring consistent categorization of repair techniques, anatomical targets, biomaterials, and end-user channels. Data validation protocols included cross-referencing country-level statistics with multinational clinical trial registries and reimbursement databases. This layered methodology enhances the reliability of insights and ensures comprehensive coverage of key market drivers and challenges.

Synthesizing Strategic Lessons and Market Trajectory

The cartilage repair and regeneration market stands at a critical inflection point, driven by technological leaps, shifting policy environments, and evolving clinical demands. A nuanced understanding of segmentation, regional dynamics, competitive strategies, and macroeconomic headwinds is essential for stakeholders seeking to capitalize on emerging opportunities. By synthesizing detailed analyses of repair techniques, biomaterial innovations, and patient segment needs, companies can refine their strategic roadmaps and anticipate future market shifts.

Ultimately, success will hinge on agility in navigating regulatory frameworks, forging collaborative innovation models, and demonstrating clear, long-term value to payers and providers. As treatment paradigms evolve from symptom management toward true tissue restoration, the capacity to integrate deep scientific expertise with commercial acumen will define the next generation of market leaders.

Market Segmentation & Coverage

This research report categorizes to forecast the revenues and analyze trends in each of the following sub-segmentations:
  • Repair Technique
    • Autologous Chondrocyte Implantation (ACI)
    • Chondroplasty
    • Microfracture
    • Mosaicplasty
    • Osteochondral Autograft Transplantation (OAT)
    • Stem Cell-Based Cartilage Regeneration
      • Adult Stem Cells
      • Embryonic Stem Cells
    • Tissue Engineering
      • Cell-Based Techniques
      • Scaffold-Based Techniques
  • Targeted Site
    • Ankle Cartilage
    • Elbow Cartilage
    • Hip Cartilage
    • Knee Cartilage
    • Shoulder Cartilage
  • Material Type
    • Natural Biomaterials
      • Chitosan-Based
      • Collagen-Based
      • Hyaluronic Acid-Based
    • Synthetic Biomaterials
      • Polyethylene Glycol (PEG)
      • Polylactic Acid (PLA)
  • Source Type
    • Allogeneic
    • Autologous
  • Application
    • Elastic Cartilage Repair
    • Fibrocartilage Repair
    • Hyaline Cartilage Repair
  • End-Users
    • Ambulatory Surgical Centers
    • Hospitals
    • Orthopedic Clinics
This research report categorizes to forecast the revenues and analyze trends in each of the following sub-regions:
  • Americas
    • United States
      • California
      • Texas
      • New York
      • Florida
      • Illinois
      • Pennsylvania
      • Ohio
    • Canada
    • Mexico
    • Brazil
    • Argentina
  • Europe, Middle East & Africa
    • United Kingdom
    • Germany
    • France
    • Russia
    • Italy
    • Spain
    • United Arab Emirates
    • Saudi Arabia
    • South Africa
    • Denmark
    • Netherlands
    • Qatar
    • Finland
    • Sweden
    • Nigeria
    • Egypt
    • Turkey
    • Israel
    • Norway
    • Poland
    • Switzerland
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • Indonesia
    • Thailand
    • Philippines
    • Malaysia
    • Singapore
    • Vietnam
    • Taiwan
This research report categorizes to delves into recent significant developments and analyze trends in each of the following companies:
  • Anika Therapeutics Inc.
  • Arthrex, Inc.
  • B. Braun SE
  • BioTissue, Inc.
  • Bioventus
  • Collagen Solutions Ltd.
  • CollPlant Biotechnologies Ltd.
  • CONMED Corporation
  • Episurf Medical AB
  • Geistlich Pharma AG
  • Integra LifeSciences Corporation
  • Isto Biologics Inc
  • Johnson & Johnson Services, Inc.
  • Kolon TissueGene, Inc.
  • MEDIPOST Co., Ltd.
  • Mesoblast Limited
  • Ocugen, Inc.
  • Orthocell Ltd.
  • Regrow Biosciences Pvt Ltd.
  • RTI Surgical, Inc.
  • Smith & Nephew PLC
  • Stryker Corporation
  • Vericel Corporation
  • Zimmer Biomet Holdings, Inc.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Cartilage Repair/Cartilage Regeneration Market, by Repair Technique
8.1. Introduction
8.2. Autologous Chondrocyte Implantation (ACI)
8.3. Chondroplasty
8.4. Microfracture
8.5. Mosaicplasty
8.6. Osteochondral Autograft Transplantation (OAT)
8.7. Stem Cell-Based Cartilage Regeneration
8.7.1. Adult Stem Cells
8.7.2. Embryonic Stem Cells
8.8. Tissue Engineering
8.8.1. Cell-Based Techniques
8.8.2. Scaffold-Based Techniques
9. Cartilage Repair/Cartilage Regeneration Market, by Targeted Site
9.1. Introduction
9.2. Ankle Cartilage
9.3. Elbow Cartilage
9.4. Hip Cartilage
9.5. Knee Cartilage
9.6. Shoulder Cartilage
10. Cartilage Repair/Cartilage Regeneration Market, by Material Type
10.1. Introduction
10.2. Natural Biomaterials
10.2.1. Chitosan-Based
10.2.2. Collagen-Based
10.2.3. Hyaluronic Acid-Based
10.3. Synthetic Biomaterials
10.3.1. Polyethylene Glycol (PEG)
10.3.2. Polylactic Acid (PLA)
11. Cartilage Repair/Cartilage Regeneration Market, by Source Type
11.1. Introduction
11.2. Allogeneic
11.3. Autologous
12. Cartilage Repair/Cartilage Regeneration Market, by Application
12.1. Introduction
12.2. Elastic Cartilage Repair
12.3. Fibrocartilage Repair
12.4. Hyaline Cartilage Repair
13. Cartilage Repair/Cartilage Regeneration Market, by End-Users
13.1. Introduction
13.2. Ambulatory Surgical Centers
13.3. Hospitals
13.4. Orthopedic Clinics
14. Americas Cartilage Repair/Cartilage Regeneration Market
14.1. Introduction
14.2. United States
14.3. Canada
14.4. Mexico
14.5. Brazil
14.6. Argentina
15. Europe, Middle East & Africa Cartilage Repair/Cartilage Regeneration Market
15.1. Introduction
15.2. United Kingdom
15.3. Germany
15.4. France
15.5. Russia
15.6. Italy
15.7. Spain
15.8. United Arab Emirates
15.9. Saudi Arabia
15.10. South Africa
15.11. Denmark
15.12. Netherlands
15.13. Qatar
15.14. Finland
15.15. Sweden
15.16. Nigeria
15.17. Egypt
15.18. Turkey
15.19. Israel
15.20. Norway
15.21. Poland
15.22. Switzerland
16. Asia-Pacific Cartilage Repair/Cartilage Regeneration Market
16.1. Introduction
16.2. China
16.3. India
16.4. Japan
16.5. Australia
16.6. South Korea
16.7. Indonesia
16.8. Thailand
16.9. Philippines
16.10. Malaysia
16.11. Singapore
16.12. Vietnam
16.13. Taiwan
17. Competitive Landscape
17.1. Market Share Analysis, 2024
17.2. FPNV Positioning Matrix, 2024
17.3. Competitive Analysis
17.3.1. Anika Therapeutics Inc.
17.3.2. Arthrex, Inc.
17.3.3. B. Braun SE
17.3.4. BioTissue, Inc.
17.3.5. Bioventus
17.3.6. Collagen Solutions Ltd.
17.3.7. CollPlant Biotechnologies Ltd.
17.3.8. CONMED Corporation
17.3.9. Episurf Medical AB
17.3.10. Geistlich Pharma AG
17.3.11. Integra LifeSciences Corporation
17.3.12. Isto Biologics Inc
17.3.13. Johnson & Johnson Services, Inc.
17.3.14. Kolon TissueGene, Inc.
17.3.15. MEDIPOST Co., Ltd.
17.3.16. Mesoblast Limited
17.3.17. Ocugen, Inc.
17.3.18. Orthocell Ltd.
17.3.19. Regrow Biosciences Pvt Ltd.
17.3.20. RTI Surgical, Inc.
17.3.21. Smith & Nephew PLC
17.3.22. Stryker Corporation
17.3.23. Vericel Corporation
17.3.24. Zimmer Biomet Holdings, Inc.
18. ResearchAI
19. ResearchStatistics
20. ResearchContacts
21. ResearchArticles
22. Appendix
List of Figures
FIGURE 1. CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET MULTI-CURRENCY
FIGURE 2. CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET MULTI-LANGUAGE
FIGURE 3. CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY REPAIR TECHNIQUE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY REPAIR TECHNIQUE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY TARGETED SITE, 2024 VS 2030 (%)
FIGURE 10. GLOBAL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY TARGETED SITE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY MATERIAL TYPE, 2024 VS 2030 (%)
FIGURE 12. GLOBAL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY MATERIAL TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY SOURCE TYPE, 2024 VS 2030 (%)
FIGURE 14. GLOBAL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY SOURCE TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 16. GLOBAL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. GLOBAL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY END-USERS, 2024 VS 2030 (%)
FIGURE 18. GLOBAL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY END-USERS, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. AMERICAS CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. AMERICAS CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. UNITED STATES CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 22. UNITED STATES CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. EUROPE, MIDDLE EAST & AFRICA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. EUROPE, MIDDLE EAST & AFRICA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. ASIA-PACIFIC CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 26. ASIA-PACIFIC CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 27. CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 28. CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY REPAIR TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY AUTOLOGOUS CHONDROCYTE IMPLANTATION (ACI), BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY CHONDROPLASTY, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY MICROFRACTURE, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY MOSAICPLASTY, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY OSTEOCHONDRAL AUTOGRAFT TRANSPLANTATION (OAT), BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY STEM CELL-BASED CARTILAGE REGENERATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY ADULT STEM CELLS, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY EMBRYONIC STEM CELLS, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY STEM CELL-BASED CARTILAGE REGENERATION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY TISSUE ENGINEERING, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY CELL-BASED TECHNIQUES, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY SCAFFOLD-BASED TECHNIQUES, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY TARGETED SITE, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY ANKLE CARTILAGE, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY ELBOW CARTILAGE, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY HIP CARTILAGE, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY KNEE CARTILAGE, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY SHOULDER CARTILAGE, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY NATURAL BIOMATERIALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY CHITOSAN-BASED, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY COLLAGEN-BASED, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY HYALURONIC ACID-BASED, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY NATURAL BIOMATERIALS, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY SYNTHETIC BIOMATERIALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY POLYETHYLENE GLYCOL (PEG), BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY POLYLACTIC ACID (PLA), BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY SYNTHETIC BIOMATERIALS, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY SOURCE TYPE, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY ALLOGENEIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY AUTOLOGOUS, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY ELASTIC CARTILAGE REPAIR, BY REGION, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY FIBROCARTILAGE REPAIR, BY REGION, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY HYALINE CARTILAGE REPAIR, BY REGION, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY ORTHOPEDIC CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 47. AMERICAS CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY REPAIR TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 48. AMERICAS CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY STEM CELL-BASED CARTILAGE REGENERATION, 2018-2030 (USD MILLION)
TABLE 49. AMERICAS CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
TABLE 50. AMERICAS CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY TARGETED SITE, 2018-2030 (USD MILLION)
TABLE 51. AMERICAS CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 52. AMERICAS CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY NATURAL BIOMATERIALS, 2018-2030 (USD MILLION)
TABLE 53. AMERICAS CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY SYNTHETIC BIOMATERIALS, 2018-2030 (USD MILLION)
TABLE 54. AMERICAS CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY SOURCE TYPE, 2018-2030 (USD MILLION)
TABLE 55. AMERICAS CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 56. AMERICAS CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 57. AMERICAS CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 58. UNITED STATES CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY REPAIR TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 59. UNITED STATES CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY STEM CELL-BASED CARTILAGE REGENERATION, 2018-2030 (USD MILLION)
TABLE 60. UNITED STATES CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
TABLE 61. UNITED STATES CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY TARGETED SITE, 2018-2030 (USD MILLION)
TABLE 62. UNITED STATES CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 63. UNITED STATES CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY NATURAL BIOMATERIALS, 2018-2030 (USD MILLION)
TABLE 64. UNITED STATES CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY SYNTHETIC BIOMATERIALS, 2018-2030 (USD MILLION)
TABLE 65. UNITED STATES CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY SOURCE TYPE, 2018-2030 (USD MILLION)
TABLE 66. UNITED STATES CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 67. UNITED STATES CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 68. UNITED STATES CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 69. CANADA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY REPAIR TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 70. CANADA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY STEM CELL-BASED CARTILAGE REGENERATION, 2018-2030 (USD MILLION)
TABLE 71. CANADA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
TABLE 72. CANADA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY TARGETED SITE, 2018-2030 (USD MILLION)
TABLE 73. CANADA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 74. CANADA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY NATURAL BIOMATERIALS, 2018-2030 (USD MILLION)
TABLE 75. CANADA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY SYNTHETIC BIOMATERIALS, 2018-2030 (USD MILLION)
TABLE 76. CANADA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY SOURCE TYPE, 2018-2030 (USD MILLION)
TABLE 77. CANADA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 78. CANADA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 79. MEXICO CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY REPAIR TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 80. MEXICO CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY STEM CELL-BASED CARTILAGE REGENERATION, 2018-2030 (USD MILLION)
TABLE 81. MEXICO CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
TABLE 82. MEXICO CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY TARGETED SITE, 2018-2030 (USD MILLION)
TABLE 83. MEXICO CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 84. MEXICO CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY NATURAL BIOMATERIALS, 2018-2030 (USD MILLION)
TABLE 85. MEXICO CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY SYNTHETIC BIOMATERIALS, 2018-2030 (USD MILLION)
TABLE 86. MEXICO CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY SOURCE TYPE, 2018-2030 (USD MILLION)
TABLE 87. MEXICO CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 88. MEXICO CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 89. BRAZIL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY REPAIR TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 90. BRAZIL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY STEM CELL-BASED CARTILAGE REGENERATION, 2018-2030 (USD MILLION)
TABLE 91. BRAZIL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
TABLE 92. BRAZIL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY TARGETED SITE, 2018-2030 (USD MILLION)
TABLE 93. BRAZIL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 94. BRAZIL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY NATURAL BIOMATERIALS, 2018-2030 (USD MILLION)
TABLE 95. BRAZIL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY SYNTHETIC BIOMATERIALS, 2018-2030 (USD MILLION)
TABLE 96. BRAZIL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY SOURCE TYPE, 2018-2030 (USD MILLION)
TABLE 97. BRAZIL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 98. BRAZIL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 99. ARGENTINA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY REPAIR TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 100. ARGENTINA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY STEM CELL-BASED CARTILAGE REGENERATION, 2018-2030 (USD MILLION)
TABLE 101. ARGENTINA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
TABLE 102. ARGENTINA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY TARGETED SITE, 2018-2030 (USD MILLION)
TABLE 103. ARGENTINA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 104. ARGENTINA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY NATURAL BIOMATERIALS, 2018-2030 (USD MILLION)
TABLE 105. ARGENTINA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY SYNTHETIC BIOMATERIALS, 2018-2030 (USD MILLION)
TABLE 106. ARGENTINA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY SOURCE TYPE, 2018-2030 (USD MILLION)
TABLE 107. ARGENTINA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 108. ARGENTINA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 109. EUROPE, MIDDLE EAST & AFRICA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY REPAIR TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 110. EUROPE, MIDDLE EAST & AFRICA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY STEM CELL-BASED CARTILAGE REGENERATION, 2018-2030 (USD MILLION)
TABLE 111. EUROPE, MIDDLE EAST & AFRICA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
TABLE 112. EUROPE, MIDDLE EAST & AFRICA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY TARGETED SITE, 2018-2030 (USD MILLION)
TABLE 113. EUROPE, MIDDLE EAST & AFRICA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 114. EUROPE, MIDDLE EAST & AFRICA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY NATURAL BIOMATERIALS, 2018-2030 (USD MILLION)
TABLE 115. EUROPE, MIDDLE EAST & AFRICA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY SYNTHETIC BIOMATERIALS, 2018-2030 (USD MILLION)
TABLE 116. EUROPE, MIDDLE EAST & AFRICA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY SOURCE TYPE, 2018-2030 (USD MILLION)
TABLE 117. EUROPE, MIDDLE EAST & AFRICA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 118. EUROPE, MIDDLE EAST & AFRICA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 119. EUROPE, MIDDLE EAST & AFRICA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 120. UNITED KINGDOM CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY REPAIR TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 121. UNITED KINGDOM CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY STEM CELL-BASED CARTILAGE REGENERATION, 2018-2030 (USD MILLION)
TABLE 122. UNITED KINGDOM CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
TABLE 123. UNITED KINGDOM CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY TARGETED SITE, 2018-2030 (USD MILLION)
TABLE 124. UNITED KINGDOM CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 125. UNITED KINGDOM CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY NATURAL BIOMATERIALS, 2018-2030 (USD MILLION)
TABLE 126. UNITED KINGDOM CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY SYNTHETIC BIOMATERIALS, 2018-2030 (USD MILLION)
TABLE 127. UNITED KINGDOM CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY SOURCE TYPE, 2018-2030 (USD MILLION)
TABLE 128. UNITED KINGDOM CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 129. UNITED KINGDOM CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 130. GERMANY CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY REPAIR TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 131. GERMANY CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY STEM CELL-BASED CARTILAGE REGENERATION, 2018-2030 (USD MILLION)
TABLE 132. GERMANY CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
TABLE 133. GERMANY CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY TARGETED SITE, 2018-2030 (USD MILLION)
TABLE 134. GERMANY CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 135. GERMANY CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY NATURAL BIOMATERIALS, 2018-2030 (USD MILLION)
TABLE 136. GERMANY CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY SYNTHETIC BIOMATERIALS, 2018-2030 (USD MILLION)
TABLE 137. GERMANY CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY SOURCE TYPE, 2018-2030 (USD MILLION)
TABLE 138. GERMANY CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 139. GERMANY CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 140. FRANCE CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY REPAIR TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 141. FRANCE CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY STEM CELL-BASED CARTILAGE REGENERATION, 2018-2030 (USD MILLION)
TABLE 142. FRANCE CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
TABLE 143. FRANCE CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY TARGETED SITE, 2018-2030 (USD MILLION)
TABLE 144. FRANCE CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 145. FRANCE CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY NATURAL BIOMATERIALS, 2018-2030 (USD MILLION)
TABLE 146. FRANCE CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY SYNTHETIC BIOMATERIALS, 2018-2030 (USD MILLION)
TABLE 147. FRANCE CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY SOURCE TYPE, 2018-2030 (USD MILLION)
TABLE 148. FRANCE CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 149. FRANCE CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 150. RUSSIA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY REPAIR TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 151. RUSSIA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY STEM CELL-BASED CARTILAGE REGENERATION, 2018-2030 (USD MILLION)
TABLE 152. RUSSIA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
TABLE 153. RUSSIA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY TARGETED SITE, 2018-2030 (USD MILLION)
TABLE 154. RUSSIA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 155. RUSSIA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY NATURAL BIOMATERIALS, 2018-2030 (USD MILLION)
TABLE 156. RUSSIA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY SYNTHETIC BIOMATERIALS, 2018-2030 (USD MILLION)
TABLE 157. RUSSIA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY SOURCE TYPE, 2018-2030 (USD MILLION)
TABLE 158. RUSSIA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 159. RUSSIA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 160. ITALY CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY REPAIR TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 161. ITALY CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY STEM CELL-BASED CARTILAGE REGENERATION, 2018-2030 (USD MILLION)
TABLE 162. ITALY CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
TABLE 163. ITALY CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY TARGETED SITE, 2018-2030 (USD MILLION)
TABLE 164. ITALY CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 165. ITALY CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY NATURAL BIOMATERIALS, 2018-2030 (USD MILLION)
TABLE 166. ITALY CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY SYNTHETIC BIOMATERIALS, 2018-2030 (USD MILLION)
TABLE 167. ITALY CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY SOURCE TYPE, 2018-2030 (USD MILLION)
TABLE 168. ITALY CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 169. ITALY CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 170. SPAIN CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY REPAIR TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 171. SPAIN CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY STEM CELL-BASED CARTILAGE REGENERATION, 2018-2030 (USD MILLION)
TABLE 172. SPAIN CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
TABLE 173. SPAIN CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY TARGETED SITE, 2018-2030 (USD MILLION)
TABLE 174. SPAIN CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 175. SPAIN CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY NATURAL BIOMATERIALS, 2018-2030 (USD MILLION)
TABLE 176. SPAIN CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY SYNTHETIC BIOMATERIALS, 2018-2030 (USD MILLION)
TABLE 177. SPAIN CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY SOURCE TYPE, 2018-2030 (USD MILLION)
TABLE 178. SPAIN CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 179. SPAIN CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 180. UNITED ARAB EMIRATES CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY REPAIR TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 181. UNITED ARAB EMIRATES CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY STEM CELL-BASED CARTILAGE REGENERATION, 2018-2030 (USD MILLION)
TABLE 182. UNITED ARAB EMIRATES CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
TABLE 183. UNITED ARAB EMIRATES CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY TARGETED SITE, 2018-2030 (USD MILLION)
TABLE 184. UNITED ARAB EMIRATES CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 185. UNITED ARAB EMIRATES CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY NATURAL BIOMATERIALS, 2018-2030 (USD MILLION)
TABLE 186. UNITED ARAB EMIRATES CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY SYNTHETIC BIOMATERIALS, 2018-2030 (USD MILLION)
TABLE 187. UNITED ARAB EMIRATES CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY SOURCE TYPE, 2018-2030 (USD MILLION)
TABLE 188. UNITED ARAB EMIRATES CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 189. UNITED ARAB EMIRATES CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 190. SAUDI ARABIA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY REPAIR TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 191. SAUDI ARABIA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY STEM CELL-BASED CARTILAGE REGENERATION, 2018-2030 (USD MILLION)
TABLE 192. SAUDI ARABIA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
TABLE 193. SAUDI ARABIA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY TARGETED SITE, 2018-2030 (USD MILLION)
TABLE 194. SAUDI ARABIA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 195. SAUDI ARABIA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY NATURAL BIOMATERIALS, 2018-2030 (USD MILLION)
TABLE 196. SAUDI ARABIA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY SYNTHETIC BIOMATERIALS, 2018-2030 (USD MILLION)
TABLE 197. SAUDI ARABIA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY SOURCE TYPE, 2018-2030 (USD MILLION)
TABLE 198. SAUDI ARABIA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 199. SAUDI ARABIA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 200. SOUTH AFRICA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY REPAIR TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 201. SOUTH AFRICA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY STEM CELL-BASED CARTILAGE REGENERATION, 2018-2030 (USD MILLION)
TABLE 202. SOUTH AFRICA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
TABLE 203. SOUTH AFRICA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY TARGETED SITE, 2018-2030 (USD MILLION)
TABLE 204. SOUTH AFRICA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 205. SOUTH AFRICA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY NATURAL BIOMATERIALS, 2018-2030 (USD MILLION)
TABLE 206. SOUTH AFRICA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY SYNTHETIC BIOMATERIALS, 2018-2030 (USD MILLION)
TABLE 207. SOUTH AFRICA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY SOURCE TYPE, 2018-2030 (USD MILLION)
TABLE 208. SOUTH AFRICA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 209. SOUTH AFRICA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 210. DENMARK CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY REPAIR TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 211. DENMARK CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY STEM CELL-BASED CARTILAGE REGENERATION, 2018-2030 (USD MILLION)
TABLE 212. DENMARK CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
TABLE 213. DENMARK CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY TARGETED SITE, 2018-2030 (USD MILLION)
TABLE 214. DENMARK CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 215. DENMARK CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY NATURAL BIOMATERIALS, 2018-2030 (USD MILLION)
TABLE 216. DENMARK CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY SYNTHETIC BIOMATERIALS, 2018-2030 (USD MILLION)
TABLE 217. DENMARK CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY SOURCE TYPE, 2018-2030 (USD MILLION)
TABLE 218. DENMARK CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 219. DENMARK CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 220. NETHERLANDS CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY REPAIR TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 221. NETHERLANDS CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY STEM CELL-BASED CARTILAGE REGENERATION, 2018-2030 (USD MILLION)
TABLE 222. NETHERLANDS CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
TABLE 223. NETHERLANDS CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY TARGETED SITE, 2018-2030 (USD MILLION)
TABLE 224. NETHERLANDS CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 225. NETHERLANDS CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY NATURAL BIOMATERIALS, 2018-2030 (USD MILLION)
TABLE 226. NETHERLANDS CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY SYNTHETIC BIOMATERIALS, 2018-2030 (USD MILLION)
TABLE 227. NETHERLANDS CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY SOURCE TYPE, 2018-2030 (USD MILLION)
TABLE 228. NETHERLANDS CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 229. NETHERLANDS CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 230. QATAR CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY REPAIR TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 231. QATAR CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY STEM CELL-BASED CARTILAGE REGENERATION, 2018-2030 (USD MILLION)
TABLE 232. QATAR CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
TABLE 233. QATAR CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY TARGETED SITE, 2018-2030 (USD MILLION)
TABLE 234. QATAR CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 235. QATAR CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY NATURAL BIOMATERIALS, 2018-2030 (USD MILLION)
TABLE 236. QATAR CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY SYNTHETIC BIOMATERIALS, 2018-2030 (USD MILLION)
TABLE 237. QATAR CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY SOURCE TYPE, 2018-2030 (USD MILLION)
TABLE 238. QATAR CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 239. QATAR CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 240. FINLAND CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY REPAIR TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 241. FINLAND CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY STEM CELL-BASED CARTILAGE REGENERATION, 2018-2030 (USD MILLION)
TABLE 242. FINLAND CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
TABLE 243. FINLAND CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY TARGETED SITE, 2018-2030 (USD MILLION)
TABLE 244. FINLAND CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 245. FINLAND CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY NATURAL BIOMATERIALS, 2018-2030 (USD MILLION)
TABLE 246. FINLAND CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY SYNTHETIC BIOMATERIALS, 2018-2030 (USD MILLION)
TABLE 247. FINLAND CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY SOURCE TYPE, 2018-2030 (USD MILLION)
TABLE 248. FINLAND CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 249. FINLAND CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 250. SWEDEN CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY REPAIR TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 251. SWEDEN CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY STEM CELL-BASED CARTILAGE REGENERATION, 2018-2030 (USD MILLION)
TABLE 252. SWEDEN CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
TABLE 253. SWEDEN CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY TARGETED SITE, 2018-2030 (USD MILLION)
TABLE 254. SWEDEN CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 255. SWEDEN CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY NATURAL BIOMATERIALS, 2018-2030 (USD MILLION)
TABLE 256. SWEDEN CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY SYNTHETIC BIOMATERIALS, 2018-2030 (USD MILLION)
TABLE 257. SWEDEN CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY SOURCE TYPE, 2018-2030 (USD MILLION)
TABLE 258. SWEDEN CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 259. SWEDEN CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 260. NIGERIA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY REPAIR TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 261. NIGERIA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY STEM CELL-BASED CARTILAGE REGENERATION, 2018-2030 (USD MILLION)
TABLE 262. NIGERIA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
TABLE 263. NIGERIA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY TARGETED SITE, 2018-2030 (USD MILLION)
TABLE 264. NIGERIA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
TABLE 265. NIGERIA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY NATURAL BIOMATERIALS, 2018-2030 (USD MILLION)
TABLE 266. NIGERIA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY SYNTHETIC BIOMATERIALS, 2018-2030 (USD MILLION)
TABLE 267. NIGERIA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY SOURCE TYPE, 2018-2030 (USD MILLION)
TABLE 268. NIGERIA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 269. NIGERIA CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
TABLE 270. EGYPT CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY REPAIR TECHNIQUE, 2018-2030 (USD MILLION)
TABLE 271. EGYPT CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY STEM CELL-BASED CARTILAGE REGENERATION, 2018-2030 (USD MILLION)
TABLE 272. EGYPT CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SIZE, BY TISSUE ENGINEERING,

Companies Mentioned

The companies profiled in this Cartilage Repair/Cartilage Regeneration market report include:
  • Anika Therapeutics Inc.
  • Arthrex, Inc.
  • B. Braun SE
  • BioTissue, Inc.
  • Bioventus
  • Collagen Solutions Ltd.
  • CollPlant Biotechnologies Ltd.
  • CONMED Corporation
  • Episurf Medical AB
  • Geistlich Pharma AG
  • Integra LifeSciences Corporation
  • Isto Biologics Inc
  • Johnson & Johnson Services, Inc.
  • Kolon TissueGene, Inc.
  • MEDIPOST Co., Ltd.
  • Mesoblast Limited
  • Ocugen, Inc.
  • Orthocell Ltd.
  • Regrow Biosciences Pvt Ltd.
  • RTI Surgical, Inc.
  • Smith & Nephew PLC
  • Stryker Corporation
  • Vericel Corporation
  • Zimmer Biomet Holdings, Inc.

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages197
PublishedMay 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 2.09 Billion
Forecasted Market Value ( USD ) by 2030 $ 3.48 Billion
Compound Annual Growth Rate10.4%
Regions CoveredGlobal
No. of Companies Mentioned25

Related Topics

Related Reports

Cartilage Repair / Cartilage Regeneration - Global Strategic Business Report - Product Image

Cartilage Repair / Cartilage Regeneration - Global Strategic Business Report

  • Report
  • 194 Pages
  • Global
From
Cartilage Regeneration Market by Type, by Treatment Modality, by Application Site, by Surgical Procedure, by End-user, and by Region - Product Image

Cartilage Regeneration Market by Type, by Treatment Modality, by Application Site, by Surgical Procedure, by End-user, and by Region

  • Report
  • 200 Pages
  • Global
From
Cartilage Repair Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update - Product Image

Cartilage Repair Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update

  • Report
  • 110 Pages
  • Global
From
Cartilage Repair Market Report 2025 - Product Image

Cartilage Repair Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Knee Cartilage Repair Market Report 2025 - Product Image

Knee Cartilage Repair Market Report 2025

  • Report
  • 200 Pages
  • Global
From

About the Cartilage Repair Market

Cartilage repair is a surgical procedure used to restore the function and integrity of damaged cartilage. Cartilage is a type of connective tissue found in the joints of the body, and it is responsible for providing cushioning and support. Damage to cartilage can occur due to injury, disease, or wear and tear. Cartilage repair procedures involve the use of grafts, implants, and other techniques to restore the damaged cartilage. The cartilage repair market is driven by the increasing prevalence of joint-related diseases, such as osteoarthritis, and the growing demand for minimally invasive procedures. The market is also driven by the development of advanced technologies, such as tissue engineering and regenerative medicine, which are used to repair damaged cartilage. Some of the key players in the cartilage repair market include Zimmer Biomet, Smith & Nephew, Stryker, Conmed Corporation, Arthrex, and DePuy Synthes. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.